These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Early treatment of Parkinson's disease with levodopa]. Odekerken VJ; Post B; Verschuur CV; de Bie RM Ned Tijdschr Geneeskd; 2009; 153():A286. PubMed ID: 19785822 [TBL] [Abstract][Full Text] [Related]
4. Overview of Parkinson's disease. Lew M Pharmacotherapy; 2007 Dec; 27(12 Pt 2):155S-160S. PubMed ID: 18041935 [TBL] [Abstract][Full Text] [Related]
5. Understanding Parkinson's disease: detection and early disease management. Mackin LA Lippincotts Prim Care Pract; 2000; 4(6):595-607. PubMed ID: 11933373 [TBL] [Abstract][Full Text] [Related]
6. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related]
7. The impact and management of nonmotor symptoms of Parkinson's disease. Lyons KE; Pahwa R Am J Manag Care; 2011 Oct; 17 Suppl 12():S308-14. PubMed ID: 22087551 [TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease--Part 2: Treatment of motor symptoms. Weintraub D; Comella CL; Horn S Am J Manag Care; 2008 Mar; 14(2 Suppl):S49-58. PubMed ID: 18402508 [TBL] [Abstract][Full Text] [Related]
10. The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptoms. Snyder CH; Adler CH J Am Acad Nurse Pract; 2007 Apr; 19(4):179-97. PubMed ID: 17430539 [TBL] [Abstract][Full Text] [Related]
12. Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairment. Chitnis S Neurol Clin; 2008 Aug; 26(3 Suppl):S29-44, v-vi. PubMed ID: 18774441 [TBL] [Abstract][Full Text] [Related]
13. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079 [TBL] [Abstract][Full Text] [Related]
18. Management of the behavioral aspects of Parkinson's disease. Borek LL; Chou KL; Friedman JH Expert Rev Neurother; 2007 Jun; 7(6):711-25. PubMed ID: 17563253 [TBL] [Abstract][Full Text] [Related]
19. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment]. Jost WH; Klasser M; Reichmann H Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504 [TBL] [Abstract][Full Text] [Related]
20. Levodopa in the early treatment of Parkinson's disease. Murata M Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]